Clinical trial
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets.
NCT05266534 is registered in ClinicalTrials.gov with Wael Elbanna Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets.
- Lead sponsor
- Wael Elbanna Clinic
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 30, 2021
- Completion date
- December 30, 2026
- Enrollment
- 162 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.